Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis - analysis of 141 cases

By Lickliter J.D.   Kratzke R.A.   Nguyen P.L.   Niehans G.A.   Miller J.S.  

Experimental Hematology, Vol. 27, Iss. 10, 1999-10 ,pp. : 1519-1527

Elsevier

Access to resources Recommend Favorite

Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis - A sequential study in 42 patients

By Hernandez-Boluda J.-C.   Cervantes F.   Colomer D.   Vela M.-C.   Costa D.   Paz M.-F.   Esteller M.   Montserrat E.  

Experimental Hematology, Vol. 31, Iss. 3, 2003-03 ,pp. : 204-210

Elsevier

Access to resources Recommend Favorite

Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia

By Henzan Hideho  

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 784-788

Springer Publishing Company

Access to resources Recommend Favorite

Non-treatment-related chronic myeloid leukemia as a second malignancy

By Specchia G.   Buquicchio C.   Albano F.   Liso A.   Pannunzio A.   Mestice A.   Rizzi R.   Pastore D.   Liso V.  

Leukemia Research, Vol. 28, Iss. 2, 2004-02 ,pp. : 115-119

Elsevier

Access to resources Recommend Favorite

Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab–bendamustine

By García-Muñoz Ricardo   García Diana   Roldán-Galiacho Verónica   Merchante-Andreu Miriam   Campeny-Najara Andrea   Rabasa Pilar  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 699-702

Springer Publishing Company

Access to resources Recommend Favorite